Astellas Settles Flomax Patent Case With U.S. Generics Maker Impax
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma has settled a patent-infringement suit against U.S.-based generics maker Impax Laboratories over the Japanese firm's Flomax (tamsulosin) prostate drug